AAV2/8-LSPhGAA (ACTUS-101)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for AAV2/8-LSPhGAA (ACTUS-101), covering 2026-04-13 to 2026-04-13. Get the full timeline:
Most recent: Clinical Trial Update: AAV2/8-LSPhGAA (ACTUS-101) in Late-Onset Pompe Disease [Phase 1]